Waters' Q3 Revenues Rise 7 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported a 7 percent climb in revenues to $401 million for the third quarter, beating Wall Street estimates of $396.7 million.

For the three months ended Oct. 2, the company' net income climbed 25 percent to $94.7 million, or $1.02 per share. Its non-GAAP EPS was $.98, above analyst estimates of $0.97 per share.

The figures compare to $374 million in revenues and $75.9 million in profits, or $0.79 per share, for Q3 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.